Founded in 1987, AMS Biotechnology (AMSBIO) has established itself as a prominent player in the acceleration of discovery within the medical, nutrition, cosmetics, and energy industries. The company's comprehensive range encompasses specialist antibodies, peptides, recombinant proteins, and in-depth expertise in extracellular matrices. AMSBIO's proficiency in cell culture allows tailored cell systems to optimize screening outcomes and prognosis, while their molecular detection reagents and Biorepository offer tissue DNA, RNA, protein, and microarray products. Key research areas include oncology, regenerative medicine, environmental analysis, cytotoxicity screening, glycomics, and stem cell biology. With headquarters in the United Kingdom, AMSBIO's contributions span diverse sectors, making it a key player in the biotechnology and healthcare industries.
AMSBIO
AMSBIO is a global supplier of research products and custom services for biological and pharmaceutical research
Abingdon, United Kingdom
30 employees
Biotechnology, Health Care
General Information
Abingdon, United Kingdom
BounceWatch is an independent company data service, not affiliated with AMSBIO. To contact AMSBIO, visit amsbio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does AMSBIO compare?
A PDF of AMSBIO and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting AMSBIO soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United Kingdom Market
Biotechnology
About AMSBIO
Business keywords: Life science technology, Biological research, Pharmaceutical research, Antibodies, Recombinant proteins, Extracellular matrices, Cell culture, Molecular detection reagents, Biorepository, Oncology, Regenerative medicine, Environmental analysis, Cytotoxicity screening, Glycomics, Stem cell biology
No funding data available for AMSBIO yet.
AMSBIO Alternatives & Competitors
View All Alternatives
Using rice as bioreactor to produce animal-free recombinant human albumin (OsrHSA)
An innovative patented and minimally invasive approach for obtaining stem cells
Democratizing Single-Cell Biotechnology
FAQ About AMSBIO
Source: BounceWatch company record for AMSBIO, https://bouncewatch.com/company/amsbio, updated 31 December 2024. When citing, please name BounceWatch and link this page.
